ESR1 and breast cancer: Moreover, by analyzing two independent BC tissue microarrays, Plaza-Menacho et al. [64] (2010) found that RET expression was associated with ER+ tumors and that there was a 2-fold increase in RET positive samples from patients who subsequently developed tamoxifen resistance compared to non-selected invasive BC[64].